Xlife Sciences AG Ratios and Metrics

Market cap in millions CHF. Fiscal year is January - December.

Millions CHF. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Apr '25 Apr 9, 2025	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Market Capitalization	113	279	157	-	-	-
Market Cap Growth	-18.77%	77.76%	-	-	-	-
Enterprise Value	262	434	321	-	-	-
Last Close Price	19.60	49.90	29.70	-	-	-
PE Ratio	7.51	18.75	10.97	-	-	-
PS Ratio	111.73	282.22	152.66	-	-	-
PB Ratio	0.41	0.76	0.47	-	-	-
P/FCF Ratio	59.25	1766.87	-	-	-	-
P/OCF Ratio	88.23	1623.87	-	-	-	-
EV/Sales Ratio	264.62	439.10	311.96	-	-	-
EV/FCF Ratio	137.95	2749.02	-	-	-	-
Debt / Equity Ratio	0.15	0.16	0.18	0.20	0.40	0.58
Debt / FCF Ratio	29.19	359.14	-	-	-	-
Asset Turnover	0.00	0.00	0.00	0.00	0.00	-
Quick Ratio	2.69	3.11	0.61	1.05	1.60	9.40
Current Ratio	2.70	3.11	0.65	1.06	1.61	9.48
Return on Equity (ROE)	4.47%	2.64%	2.67%	23.71%	18.56%	-
Return on Assets (ROA)	-2.36%	-2.53%	-2.70%	-0.98%	-1.14%	-
Return on Capital (ROIC)	-2.88%	-3.09%	-3.36%	-1.16%	-1.15%	-
Earnings Yield	18.87%	5.33%	9.12%	-	-	-
FCF Yield	1.69%	0.06%	-2.95%	-	-	-
Buyback Yield / Dilution	-12.33%	0.17%	-17.26%	-4.77%	-60.85%	-

Updated Sep 18, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.